# MIMRYLO

NDC: 63020-765
Generic name: rusfertide
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: SUBCUTANEOUS
Marketing started: 20260828

FDA application: NDA220605

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63020-765"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63020-765
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=101aff01-31ed-4841-a8b6-0a5a8503189b